Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

Rhea-AI Summary

Merit Medical Systems (NASDAQ: MMSI), a leading healthcare technology manufacturer, has scheduled its second quarter 2025 financial results announcement for July 30, 2025, after market close. The company will host an investor conference call the same day at 5:00 p.m. Eastern Time.

Founded in 1987, Merit Medical specializes in proprietary medical devices for interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. The company maintains a global presence with over 800 sales and clinical support professionals and approximately 7,300 employees worldwide.

News Market Reaction

-2.63%

1 alert

-2.63% News Effect

On the day this news was published, MMSI declined 2.63%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2025, after the close of the stock market on Wednesday, July 30, 2025. Merit plans to hold its investor conference call on the same day (Wednesday, July 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).

To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.

A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.

ABOUT MERIT

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,300 people worldwide.

Contacts:
PR/Media Inquiries:	Investor Inquiries:
Sarah Comstock	Mike Piccinino, CFA, IRC
Merit Medical	ICR Healthcare
+1-801-432-2864	+1-443-213-0509
sarah.comstock@merit.com	mike.piccinino@icrhealthcare.com

FAQ

When will Merit Medical (MMSI) report Q2 2025 earnings?

Merit Medical will release Q2 2025 earnings on Wednesday, July 30, 2025 after the stock market closes, followed by a conference call at 5:00 p.m. Eastern Time.

How can investors access Merit Medical's Q2 2025 earnings call?

Investors must pre-register for the conference call to receive dial-in details. A live webcast and slide deck will also be available through Merit's website at www.merit.com.

What are Merit Medical's main business segments?

Merit Medical specializes in medical devices for interventional, diagnostic, and therapeutic procedures, focusing on cardiology, radiology, oncology, critical care, and endoscopy.

How many employees does Merit Medical (MMSI) have?

Merit Medical employs approximately 7,300 people worldwide and has a global sales and clinical support team of over 800 individuals.